Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for UGT1A1 and Atazanavir Prescribing.

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for UGT1A1 and Atazanavir Prescribing. Clin Pharmacol Ther. 2016 Apr; 99(4):363-9.

View in: PubMed

subject areas

Atazanavir Sulfate
Genetic Predisposition to Disease
Genotype
Glucuronosyltransferase
HIV Protease Inhibitors
Humans
Hyperbilirubinemia
Jaundice
Liver
Pharmacogenetics
Phenotype
Risk Assessment
Risk Factors

authors with profiles

Mark J. Ratain